SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 79 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,528,081 | -38.0% | 15,898,729 | -4.5% | 0.01% | -37.5% |
| Q2 2023 | $99,198,628 | +65.7% | 16,644,065 | -9.1% | 0.01% | +166.7% |
| Q1 2023 | $59,867,768 | +65.3% | 18,308,186 | +99.7% | 0.00% | -25.0% |
| Q4 2022 | $36,219,169 | -34.4% | 9,169,410 | -0.4% | 0.00% | -33.3% |
| Q3 2022 | $55,240,000 | -11.9% | 9,206,685 | -5.6% | 0.01% | 0.0% |
| Q2 2022 | $62,684,000 | -17.8% | 9,748,674 | +5.6% | 0.01% | 0.0% |
| Q1 2022 | $76,290,000 | -42.9% | 9,236,067 | +7.0% | 0.01% | -40.0% |
| Q4 2021 | $133,559,000 | -29.8% | 8,627,851 | +2.1% | 0.01% | -33.3% |
| Q3 2021 | $190,356,000 | +13.3% | 8,452,744 | -1.1% | 0.02% | +15.4% |
| Q2 2021 | $168,076,000 | -42.5% | 8,549,177 | -2.1% | 0.01% | -48.0% |
| Q1 2021 | $292,373,000 | – | 8,735,390 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $530,020,000 | 8.19% |
| Crestline Management, LP | 3,210,937 | $49,705,000 | 3.71% |
| SB Management Ltd | 2,209,004 | $34,195,000 | 3.38% |
| Omega Fund Management, LLC | 843,750 | $13,061,000 | 1.85% |
| Alphabet Inc. | 2,812,500 | $43,538,000 | 1.05% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $5,999,000 | 0.84% |
| HARVARD MANAGEMENT CO INC | 468,749 | $7,256,000 | 0.68% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $63,952,000 | 0.34% |
| Dragoneer Investment Group | 1,500,000 | $23,220,000 | 0.27% |
| Artal Group S.A. | 400,000 | $6,192,000 | 0.17% |